Sell signal in observation · week 2
Regeneron bounces 1.5% off its 50-week average as the Sell signal loses its push
Our view last week
A 6.7% drop in a single week has pushed Regeneron back below its 20-week average, in the 746 area, and fired a fresh Sell signal: a week ago our technical analysis was still tracking a buy. Regeneron stock has stopped, though, right on top of a band of supports, with the 50- and 200-week averages in the 722 area. For our model, opening a short here is high-risk: among US stocks, this is a setup to watch through the confirmation week.
This week's summary
The band of supports held: this week Regeneron slid down to its 50-week average, in the 723 area, and climbed back from there to close up 1.5%, right on its 20-week average. The Sell signal fired a week ago has lost its push, even as the daily chart still shows lower highs. In our technical analysis Regeneron stock is squeezed between two nearby levels: opening a short here stays high-risk among US stocks, and price action will show which side gives way.
Sell signal in observation
·2nd week from start
·US stocks
·T2
·📅 Earnings · Oct 30
★ See Gold version →
IQS Phase
44
ordinary
Signal Strength
34
decline losing steam
Sizing
REDUCED
Ranking
#43 / 174
US stocks sell signals
Trade P&L %
-1.54%
from signal to date, no stop loss
Regeneron Pharmaceuticals (REGN) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 43rd among the 174 sell signals for US stocks in our ranking, with a signal strength of 34 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +2.79% · monthly +2.54%
REGN belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content